Diametric Capital LP Invests $217,000 in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Diametric Capital LP bought a new stake in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 95,161 shares of the company’s stock, valued at approximately $217,000. Diametric Capital LP owned approximately 0.11% of Stereotaxis as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in STXS. Charles Schwab Investment Management Inc. boosted its position in shares of Stereotaxis by 10.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock valued at $341,000 after purchasing an additional 15,491 shares in the last quarter. State Street Corp boosted its holdings in Stereotaxis by 5.7% in the third quarter. State Street Corp now owns 680,612 shares of the company’s stock worth $1,388,000 after acquiring an additional 36,518 shares in the last quarter. Jane Street Group LLC boosted its holdings in Stereotaxis by 26.9% in the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock worth $61,000 after acquiring an additional 6,313 shares in the last quarter. Barclays PLC grew its stake in shares of Stereotaxis by 449.9% in the third quarter. Barclays PLC now owns 101,953 shares of the company’s stock worth $208,000 after acquiring an additional 83,412 shares during the last quarter. Finally, Geode Capital Management LLC increased its holdings in shares of Stereotaxis by 7.2% during the third quarter. Geode Capital Management LLC now owns 1,391,718 shares of the company’s stock valued at $2,840,000 after acquiring an additional 93,253 shares in the last quarter. Institutional investors own 45.35% of the company’s stock.

Insider Transactions at Stereotaxis

In other news, Director Paul J. Isaac bought 38,000 shares of the stock in a transaction on Monday, March 10th. The shares were bought at an average price of $1.81 per share, with a total value of $68,780.00. Following the completion of the acquisition, the director now owns 87,299 shares in the company, valued at $158,011.19. The trade was a 77.08 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 18.52% of the company’s stock.

Stereotaxis Stock Up 2.3 %

Shares of STXS opened at $1.75 on Thursday. The company has a market capitalization of $148.28 million, a P/E ratio of -6.25 and a beta of 1.54. Stereotaxis, Inc. has a twelve month low of $1.62 and a twelve month high of $3.29. The firm’s 50 day moving average price is $2.12.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.